Patents by Inventor Cantrell John L.

Cantrell John L. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4435386
    Abstract: A pharmaceutical composition comprising refined detoxified endotoxin, trehalose dimycolate, and an acetone precipitated by-product of endotoxic glycolipids extracted with chloroform-methanol (ACP) is disclosed which is useful for the treatment of cancerous tumors. Methods of using the composition for these purposes are also disclosed.
    Type: Grant
    Filed: May 26, 1982
    Date of Patent: March 6, 1984
    Assignee: Ribi ImmunoChem Research, Inc.
    Inventors: Edgar E. Ribi, Cantrell John L.